Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells-Reference-Cited by-同舟云学术

Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells

Published:2016-03-30 Issue:4 Volume:27 Page:1050-1057
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Wischnjow Artjom¹,Sarko Dikran¹,Janzer Maria¹²,Kaufman Christina¹,Beijer Barbro¹,Brings Sebastian¹,Haberkorn Uwe¹,Larbig Gregor²,Kübelbeck Armin²,Mier Walter¹

Affiliation:

1. Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany

2. Merck KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.6b00057

Reference39 articles.

1. Metabolism and Transport of Oxazaphosphorines and the Clinical Implications

2. Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

3. Radiogene Nephropathie

4. Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine

5. Subcellular targeting strategies for drug design and delivery

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotherapeutic kidney cell-specific targeting to ameliorate acute kidney injury;Kidney International;2024-07

2. Kidney targeted delivery of siRNA mediated by peptide-siRNA conjugate for the treatment of acute kidney injury;Chinese Chemical Letters;2024-07

3. Programmable DNA Scaffolds Enable Orthogonal Engineering of Cell Membrane-Based Nanovesicles for Therapeutic Development;Nano Letters;2024-06-10

4. Layer‐by‐Layer Assembly of Renal‐Targeted Polymeric Nanoparticles for Robust Arginase‐2 Knockdown and Contrast‐Induced Acute Kidney Injury Prevention;Advanced Healthcare Materials;2024-05-08

5. BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury;Biomedicine & Pharmacotherapy;2024-05